Vaccination or Infection and the Role of T Cells—the Response to Cancer, Autoimmunity or Inflammatory Diseases
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Cancer Vaccines and Immunotherapy".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 861
Special Issue Editor
Interests: inflammation and immune regulation; T-cell immunology; adrenergic α2 receptors; anesthesia and immune modulation; anti-infective immunity
Special Issue Information
Dear Colleagues,
The roles of T cells in cancer, autoimmune, and inflammatory diseases represent an area of rapidly advancing research, providing crucial insights into immune regulation and disease development. T cells play a key role in regulating immune responses and orchestrating immune reactions through their various subpopulations and adaptable functions. In cancer, T cells can promote anti-tumor immunity, but they can also contribute to tumor immune evasion and resistance to immunotherapy. In autoimmune and inflammatory diseases, imbalanced T-cell responses can lead to persistent inflammation and tissue damage. Understanding the mechanisms behind T-cell function and dysfunction is critical for developing targeted therapies that regulate T-cell activity, offering promising approaches for treating a range of diseases.
For this Special Issue, we request original research, reviews, and studies that deepen our understanding of T-cell biology, their roles in disease, and innovative therapeutic strategies targeting T cells.
Prof. Dr. Yuedan Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- T-cell biology
- cancer immunotherapy
- autoimmune diseases
- inflammatory diseases
- immune modulation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
